Targeted Therapeutics Consulting is interested in a broad representation of expert opinion in our database.

We have generated a unique combination of an annotatable relational database and online collaboration tools that provides an

ideal platform for ongoing, up-to-date expert discussions.

You'll get free access to the Targeted Therapeutics Consulting database.

We want your expertise!

We'll ask you to identify one or two areas of your expertise. We'll then assign to you an area in the database for which we would like your input.

We'll ask you annotate drug or clinical trial data with your scientific opinion. To maintain your free subscription status, you'll have to comment on the target areas (e.g. a particular drug, a drug class, trials in a certain disease etc.) once every three months.

If you prefer, we'll keep your annotations anonymous.

Your annotations will be subject of editorial review. We reserve to remove inappropriate of offensive annotations. However, the editorial review will be independent from and not influenced by our industry customers.

GO BACK